Related references
Note: Only part of the references are listed.Vaccine-induced immune thrombotic thrombocytopenia
Frederikus A. Klok et al.
LANCET HAEMATOLOGY (2022)
Eosinophilic Granulomatosis with Polyangiitis Relapse after COVID-19 Vaccination: A Case Report
Giulia Costanzo et al.
VACCINES (2022)
SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study
Michele Maria Luchetti Gentiloni et al.
FRONTIERS IN IMMUNOLOGY (2022)
Booster COVID-19 Vaccines for Immune-Mediated Inflammatory Disease Patients: A Systematic Review and Meta-Analysis of Efficacy and Safety
Ainsley Ryan Yan Bin Lee et al.
VACCINES (2022)
New Onset of Eosinophilic Granulomatosis with Polyangiitis Following mRNA-Based COVID-19 Vaccine
Emanuele Nappi et al.
VACCINES (2022)
Recrudescence of severe polyneuropathy after receiving Pfizer-BioNTech COVID-19 vaccine in a patient with a history of eosinophilic granulomatosis with polyangiitis
Rahul Gill et al.
BMJ CASE REPORTS (2022)
Autoimmune Rheumatic Disease Flares with Myocarditis Following COVID-19 mRNA Vaccination: A Case-Based Review
Yi Wye Lai et al.
VACCINES (2022)
Immune-mediated inflammatory diseases after anti-SARS-CoV-2 vaccines: new diagnoses and disease flares
Francesco Carubbi et al.
RMD OPEN (2022)
Case Report: ANCA-Associated Vasculitis Presenting With Rhabdomyolysis and Pauci-Immune Crescentic Glomerulonephritis After Pfizer-BioNTech COVID-19 mRNA Vaccination
Samy Hakroush et al.
FRONTIERS IN IMMUNOLOGY (2021)
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
Marie Scully et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination
Abdulla Watad et al.
VACCINES (2021)
Thrombosis With Thrombocytopenia After the Messenger RNA-1273 Vaccine
Swathi Sangli et al.
ANNALS OF INTERNAL MEDICINE (2021)
Thrombosis After Vaccination With Messenger RNA-1273: Is This Vaccine-Induced Thrombosis and Thrombocytopenia or Thrombosis With Thrombocytopenia Syndrome?
Allyson M. Pishko et al.
ANNALS OF INTERNAL MEDICINE (2021)
Hypereosinophilia: a rare cause of stroke and multiorgan dysfunction
Kapil L. Barbind et al.
BMJ CASE REPORTS (2021)
Vaccinations and Autoimmune Diseases
Bianca Olivieri et al.
VACCINES (2021)
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
E. J. Anderson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Thrombotic microangiopathy in a patient with eosinophilic granulomatosis with polyangiitis: case-based review
Jon Badiola et al.
RHEUMATOLOGY INTERNATIONAL (2019)
Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis
Vitor Teixeira et al.
RMD OPEN (2019)
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management
Matthieu Groh et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2015)
Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial
Waleed Ghanima et al.
LANCET (2015)
Eosinophilic granulomatosis with polyangiitis: an overview
Andrea Gioffredi et al.
FRONTIERS IN IMMUNOLOGY (2014)